The novel diagnostic techniques and biomarkers of canine mammary tumors

I Kaszak, O Witkowska-Piłaszewicz, K Domrazek… - Veterinary …, 2022 - mdpi.com
Simple Summary The high rate of cancers in both humans and in animals along with their
poor overall survival pose a major challenge in medicine. Therefore, a large amount of …

Canine mammary cancer: State of the art and future perspectives

E Vazquez, Y Lipovka, A Cervantes-Arias… - Animals, 2023 - mdpi.com
Simple Summary Mammary tumors are the most frequent neoplasia in female dogs. They
develop spontaneous cancer and share several biological, clinical, pathological and …

[HTML][HTML] Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer

D Alonso-Miguel, G Valdivia, D Guerrera… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Inflammatory mammary cancer (IMC), the counterpart of human inflammatory
breast cancer (IBC), is the deadliest form of canine mammary tumors. IMC patients lack …

Lymphatic drainage mapping with indirect lymphography for canine mammary tumors

F Collivignarelli, R Tamburro, G Aste, I Falerno… - Animals, 2021 - mdpi.com
Simple Summary Mammary gland tumours are the most common canine neoplasms. They
account for 25–50% of all tumors diagnosed in bitches. Metastases and recurrences …

Canine mammary tumors: classification, biomarkers, traditional and personalized therapies

N Nosalova, M Huniadi, Ľ Horňáková… - International Journal of …, 2024 - mdpi.com
In recent years, many studies have focused their attention on the dog as a proper animal
model for human cancer. In dogs, mammary tumors develop spontaneously, involving a …

Neoadjuvant intratumoral immunotherapy with cowpea mosaic virus induces local and systemic antitumor efficacy in canine mammary cancer patients

G Valdivia, D Alonso-Miguel, MD Perez-Alenza… - Cells, 2023 - mdpi.com
The lack of optimal models to evaluate novel agents is delaying the development of effective
immunotherapies against human breast cancer (BC). In this prospective open label study …

Synergistic Anti-Cancer Effects of ERB-041 and Genistein through Estrogen Receptor Suppression-Mediated PI3K/AKT Pathway Downregulation in Canine Mammary …

MJ Yoo, YJ Jang, SY Park, JW Choi… - International Journal of …, 2024 - mdpi.com
Canine-mammary-gland tumors (CMTs) are prevalent in female dogs, with approximately
50% of them being malignant and often presenting as inoperable owing to their size or …

[HTML][HTML] MicroRNA-124 inhibits canine mammary carcinoma cell proliferation, migration and invasion by targeting CDH2

X Ren, Y Fan, D Shi, E Xu, Y Liu - Research in Veterinary Science, 2022 - Elsevier
Canine mammary carcinoma (CMC) is the most common malignant tumor and the second
leading cause of cancer-related mortality of dogs worldwide. MicroRNA-124 (miR-124) is an …

Research progress of good markers for canine mammary carcinoma

NY Yang, HH Zheng, C Yu, Y Ye, CT Du… - Molecular Biology …, 2023 - Springer
Purpose Mammary gland tumors are the most common neoplastic diseases in elderly
female dogs, about 50% of which are considered to be malignant. Canine mammary tumors …

SFRP1 expression is inversely Associated with Metastasis formation in Canine Mammary Tumours

J Seitz, A Bilsland, C Puget, I Baasner… - Journal of Mammary …, 2023 - Springer
Abstract Background Canine mammary tumours (CMTs) are the most frequent tumours in
intact female dogs and show strong similarities with human breast cancer. In contrast to the …